Tech Company Financing Transactions
Moderna Funding Round
Flagship Pioneering and private investors invested in a $40 million funding round for Moderna. The round closed on 12/6/2012.
Transaction Overview
Company Name
Announced On
12/6/2012
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Undisclosed
Investors
Flagship Pioneering (Noubar Afeyan)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
200 Technology Sq.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
At Moderna (Nasdaq: MRNA), we are pioneering the development of a new class of drugs made of messenger RNA (mRNA).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stéphane Bancel
Chief Medical Officer
Tal Zaks
President
Stephen Hoge
VP - General Counsel
Lori Henderson
VP - Manufacturing
Juan Andres
Browse more venture capital transactions:
Prev: 12/6/2012: Roboinvest venture capital transaction
Next: 12/6/2012: Prismatic venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to record tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs